These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Symptomatic treatment of multiple sclerosis]. Ayuso-Peralta L; de Andrés C Rev Neurol; 2002 Dec 16-31; 35(12):1141-53. PubMed ID: 12497297 [TBL] [Abstract][Full Text] [Related]
6. [Symptomatic therapies for multiple sclerosis]. Honda H Nihon Rinsho; 2003 Aug; 61(8):1355-60. PubMed ID: 12962023 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726 [TBL] [Abstract][Full Text] [Related]
8. Managing the symptoms of multiple sclerosis: a multimodal approach. Crayton HJ; Rossman HS Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459 [TBL] [Abstract][Full Text] [Related]
9. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. Rekand T; Grønning M J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331 [TBL] [Abstract][Full Text] [Related]
10. Palliative care in patients with multiple sclerosis. Ben-Zacharia AB; Lublin FD Neurol Clin; 2001 Nov; 19(4):801-27. PubMed ID: 11854101 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis. Hawker K; Frohman E Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166 [No Abstract] [Full Text] [Related]
12. Therapeutic and symptomatic treatment of multiple sclerosis. Rosenblum D; Saffir M Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):587-601, vi-vii. PubMed ID: 9894111 [TBL] [Abstract][Full Text] [Related]
13. Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. DeLuca J; Nocentini U NeuroRehabilitation; 2011; 29(3):197-219. PubMed ID: 22142753 [TBL] [Abstract][Full Text] [Related]
15. Spasticity, ataxia and fatigue in multiple sclerosis. Kesselring J; Thompson AJ Baillieres Clin Neurol; 1997 Oct; 6(3):429-45. PubMed ID: 10101582 [TBL] [Abstract][Full Text] [Related]
16. A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis. Arroyo González R Expert Rev Neurother; 2018 Oct; 18(10):785-791. PubMed ID: 30235965 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal baclofen for muscle spasticity and pain--two case reports. Al Khudhairi D; Rababa A; Saddiqui MN Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537 [No Abstract] [Full Text] [Related]
18. Managing specific symptoms in people with multiple sclerosis. Henze T Int MS J; 2005 Aug; 12(2):60-8. PubMed ID: 16417816 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological treatment of spasticity in multiple sclerosis]. Heinzlef O; Monteil-Roch I Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367 [TBL] [Abstract][Full Text] [Related]
20. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Hoogstraten MC; van der Ploeg RJ; vd Burg W; Vreeling A; van Marle S; Minderhoud JM Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]